According to Novo Nordisk, it is critical that the United States health and wellness authorities select to control “based on existing clinical scientific research”.
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/us-halt-to-obesity-drug-reimbursement-disappoints-novo-nordisk-and-eli-lilly/